NUTEX HEALTH INC. (NUTX) Net margin 2017–2025
NUTEX HEALTH INC. (NUTX) net profit margin by fiscal year — reported net income divided by reported revenue.
8.1%FY2025 · since FY2017: 2512.6% → 8.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 8.1% | -2.8 pp |
| FY2024 | 10.9% | +29.3 pp |
| FY2023 | -18.5% | +175.2 pp |
| FY2022 | -193.7% | -233.7 pp |
| FY2021 | 40.0% | +1.3 pp |
| FY2020 | 38.7% | +559.5 pp |
| FY2019 | -520.8% | -451.3 pp |
| FY2018 | -69.5% | -2582.1 pp |
| FY2017 | 2512.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More NUTX financial trends
NUTX RevenueNUTX Net incomeNUTX Gross profitNUTX Gross marginNUTX Operating incomeNUTX Operating marginNUTX Operating cash flowNUTX Free cash flowNUTX Capital expendituresNUTX Return on equityNUTX Stock buybacksNUTX Dividends paidNUTX Total assetsNUTX Total liabilitiesNUTX Shareholders’ equityNUTX overview →